Loading...
By Amy Orciari Herman
Edited by David G. Fairchild, MD, MPH
Three papers in the BMJ take a close look at screening programs and the potential for overdiagnosis.
The first analysis examines screening for abdominal aortic aneurysms (in the U.S., one-time screening is recommended for men aged 65–75 who've ever smoked). The authors note that screening generally identifies small aneurysms, which are unlikely to rupture. Moreover, preventive surgery carries substantial risks, including myocardial infarction and renal failure.
In the second paper, a public health professor calls for experts to agree on how often breast cancer is overdiagnosed so that women can make informed screening and treatment decisions. She notes: "Although it is not a life threatening condition, screen detected [ductal carcinoma in situ] is treated similarly to invasive breast cancer. Thus, overdiagnosis inadvertently turns some well women into patients who are exposed to all the risks of cancer treatments."
The third paper reports results from a survey of 1000 U.K. adults who were asked how much overdetection they would find acceptable in screenings for breast, prostate, or colon cancer. Across all cancer types, 4%–7% of participants said they would accept no overdetection, while 7%–14% said it would be OK for cancer to be overdetected in the entire screened population.
Comment
LINK(S):
BMJ article on AAAs (Free)
BMJ article on breast cancer screening (Free)
BMJ article on acceptance of overdetection (Free)
Background: NEJM Journal Watch Women's Health coverage of women's knowledge of breast cancer overdiagnosis (Your NEJM Journal Watch registration required)